Search

Emergent BioSolutions Inc

Suletud

SektorTervishoid

7.46 -1.58

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.44

Max

7.58

Põhinäitajad

By Trading Economics

Sissetulek

61M

6.8M

Müük

7.4M

156M

P/E

Sektori keskmine

8.634

62.58

Aktsiakasum

0.21

Kasumimarginaal

4.356

Töötajad

900

EBITDA

42M

49M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+58.31% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-18M

397M

Eelmine avamishind

9.04

Eelmine sulgemishind

7.46

Uudiste sentiment

By Acuity

100%

0%

319 / 340 Pingereas Healthcare

Emergent BioSolutions Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. juuli 2026, 10:46 UTC

Social Media
News

Knight-Swift Transportation reported strong Q2 results, with revenue of $2.1 billion and adjusted EPS of $0.63, but shares are lower in pre-market trading.

23. juuli 2026, 10:46 UTC

Social Media
News
Correlated Moves

Northrop Grumman Corp secured a $1.2 billion contract for E-2D aircraft production, boosting shares in pre-market trading amid positive investor sentiment.

23. juuli 2026, 10:46 UTC

News

Blackstone Inc has launched two hybrid investment funds to expand access to alternative investments. Shares are trading higher since Wednesday's close, despite earlier losses.

23. juuli 2026, 10:46 UTC

News

Barclays lowered Pegasystems' price target to $39.00 from $48.00, maintaining an Overweight rating. Shares are trading lower in pre-market hours.

23. juuli 2026, 10:46 UTC

News
Social Media

Intel is finalizing long-term purchase commitments for data-center processors in China, driven by AI demand. Shares are higher in pre-market trading ahead of earnings.

23. juuli 2026, 10:46 UTC

News

Geopolitical tensions are impacting the US 10Y Treasury Bond Index. As a result, Vanguard Total Bond Market ETF is trading roughly flat during pre-market hours.

23. juuli 2026, 10:46 UTC

News

Community Health Systems shares lower in pre-market after Barclays cut the price target to $2.50, following a decline in net income and revenues.

23. juuli 2026, 10:42 UTC

News

Coca-Cola recognized as a top dividend stock, offering a quarterly dividend of $0.53 per share. Shares are higher in pre-market trading.

23. juuli 2026, 10:36 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is slightly higher in pre-market trading, supported by strong performances from key holdings, despite broader market caution ahead of the ECB decision.

23. juuli 2026, 10:36 UTC

News

Schlumberger NV reports $8.72 billion in quarterly revenue, down 6.3% year-over-year. Shares advance in pre-market trading, supported by positive sector sentiment.

23. juuli 2026, 10:36 UTC

Social Media
News

General Motors shares are higher in pre-market trading following strong Q2 results and price target increases from TD Cowen and Goldman Sachs.

23. juuli 2026, 10:32 UTC

Social Media
News

Hewlett Packard Enterprise shares are higher in pre-market trading, supported by strong investor interest in AI infrastructure and positive sector sentiment following Dell's gains.

23. juuli 2026, 10:26 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF trades roughly flat in pre-market hours as major tech firms prepare to report quarterly earnings, influencing investor focus on AI and cloud growth.

23. juuli 2026, 10:26 UTC

News

Fortinet Inc. has been named Intel's first external customer for its foundry business, producing the SP6 security chip. Shares are higher in pre-market hours.

23. juuli 2026, 10:26 UTC

News
Correlated Moves

ConocoPhillips shares are higher in pre-market trading, reflecting a positive response to rising WTI crude prices amid escalating Middle East tensions.

23. juuli 2026, 10:26 UTC

News

Nasdaq Inc is advancing in pre-market trading as it prepares to implement new delisting rules for underperforming microcap companies following SEC approval.

23. juuli 2026, 10:16 UTC

News

PagSeguro Digital shares are lower in pre-market trading following Jefferies' Hold rating and price target of $10.40, after closing at $9.67.

23. juuli 2026, 10:16 UTC

News
Event

Arrowhead Pharmaceuticals shares rise in pre-market trading, building on Wednesday's gains after positive drug trial results and a price target increase to $115 from $90.

23. juuli 2026, 10:16 UTC

News

DigitalOcean Holdings sees strong demand for AI data centers, with $800 million in remaining performance obligations. Shares are higher in pre-market trading.

23. juuli 2026, 10:16 UTC

News

American Electric Power shares are lower in pre-market trading amid ongoing performance weakness, despite the appointment of two new board members.

23. juuli 2026, 10:16 UTC

Social Media
News

Netflix Inc. shares are higher in pre-market trading, supported by strong Movies & Entertainment sector performance and robust EBITDA of $8.66 billion.

23. juuli 2026, 10:16 UTC

News
Social Media

Advanced Micro Devices is finalizing long-term CPU commitments in China, driven by AI demand. Shares are higher in pre-market trading amid these developments.

23. juuli 2026, 10:16 UTC

Social Media
News
Correlated Moves

Apple Inc shares are lower in pre-market trading amid a broader market downturn and challenges in foldable iPhone production, though the launch schedule remains on track.

23. juuli 2026, 10:11 UTC

News

Autodesk shares rise in pre-market after Guggenheim Buy rating.

23. juuli 2026, 10:11 UTC

News

Southwest Airlines shares are lower in pre-market trading after the company issued third-quarter guidance below consensus and revised full-year EPS expectations downward.

23. juuli 2026, 10:11 UTC

News

American Airlines shares are trading lower in pre-market hours as higher jet fuel costs weigh on earnings projections ahead of upcoming results.

23. juuli 2026, 10:11 UTC

Social Media
News

Kinder Morgan shares are higher in pre-market trading following strong second-quarter results, including record net income of $867 million and a dividend increase to $0.2975.

23. juuli 2026, 10:11 UTC

News

Teledyne Technologies announced a five-year partnership with the Royal National Lifeboat Institution to enhance lifeboat technology. Needham raised its price target to $750.

23. juuli 2026, 10:06 UTC

Social Media
News

Micron Technology shares higher in pre-market trading following a Motley Fool prediction of $1,400 by 2027, citing strong revenue growth and strategic agreements.

23. juuli 2026, 10:06 UTC

News

EQT Corp's stock rises in pre-market trading after raising full-year natural gas production guidance and securing long-term supply agreements.

Võrdlus sarnastega

Hinnamuutus

Emergent BioSolutions Inc Prognoos

Hinnasiht

By TipRanks

58.31% tõus

12 kuu keskmine prognoos

Keskmine 12 USD  58.31%

Kõrge 12 USD

Madal 12 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Emergent BioSolutions Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

319 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Emergent BioSolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
help-icon Live chat